Vincent Guillaumot - Profile and Investment Details

Investor Profile

Vincent Guillaumot is a Venture Capital, Private Equity Firm based in Tokyo, Tokyo, Japan with a diverse investment portfolio that includes companies such as Zytomed Systems GmbH, Cardioline, Clean Cells, DIESSE Diagnostica Senese S.p.A., Vita Health Group - Physical and Mental Wellbeing specialists, 3i, InstemNatural Origins, Eurolyser Diagnostica, Micromed, Primo Group, Title21 Health Solutions, Primo Group S.p.A., JS Bio, Ad-Tech Medical Instrument Corporation, Citieffe s.r.l., Natus Medical Incorporated, Centri Dentistici Primo, . Over time, Vincent Guillaumot has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Vincent Guillaumot is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Corporate Wellness, Wellness, Investment Management, Healthcare Innovation, Life Science, Medical Technologies, Business Development, Finance, Manufacturing, Biotechnology, Healthcare IT, Consumer Health, Medical Devices, Innovation, Social Impact, Renewable Energy, Medical, B2B, Health Tech, Pharmaceuticals, Healthcare Technology, Professional Development, Acquisitions may find it worthwhile to explore potential connections with Vincent Guillaumot, as their portfolio suggests a familiarity and interest in this area.

Understanding Vincent Guillaumot’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.